Sector Watch: Healthcare - Oct 05 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $116.53 -1.35 -1.15% | XBI: $90.45 -1.39 -1.51% | Updated Oct 05, 2018 04:26 PM
HEALTHCARE STOCKS - TOP GAINERS | ||||
---|---|---|---|---|
BLPH Bellerophon Therapeutics $69.4M |
1.20+0.12 1.4 M 1.6x |
11% | ||
CIVI Civitas Solutions $581.8M |
16.06+1.51 135.9 K 3.5x |
10% | ||
CRMD CorMedix Inc $127.2M |
1.30+0.12 6.1 M 1.8x |
10% | ||
SSH Sunshine Heart Inc $719.8M |
68.50+6.00 0.2 K |
10% | ||
VBIV VBI Vaccines $144.9M |
2.41+0.16 351.4 K |
7% |
HEALTHCARE STOCKS - TOP LOSERS | ||||
---|---|---|---|---|
CUTR52WL Cutera $304.7M |
22.02-7.76 1.4 M 8.1x |
-26% | ||
LMAT52WL LeMaitre Vascular $555.3M |
28.53-7.44 1.3 M 12.6x |
-21% | ||
MDXG MiMedx Group Inc $627.4M |
5.65-0.80 3.7 M |
-12% | ||
MRNS Marinus Pharmaceuticals $317.3M |
7.83-0.95 1.4 M 1.9x |
-11% | ||
CDNA CareDx $864.0M |
23.77-2.66 762.1 K |
-10% |
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) [globenewswire.com]Cutera Updates Full Year 2018 Revenue Guidance [globenewswire.com]
Kidney Policy Summit Elevates Innovation Over Status Quo [prnewswire.com]
VBI Vaccines? Late-Breaker Cytomegalovirus Abstract Chosen for Oral Presentation at IDWeek 2018 [globenewswire.com]
Trevena announces completion of leadership transition and appointment of new director [globenewswire.com]
VBI Vaccines to Present at the Ladenburg Thalmann 2018 Healthcare Conference [globenewswire.com]
LeMaitre Vascular Acquires Clot Management Business from Applied Medical [globenewswire.com]
VBI Vaccines Announces Formation of New Scientific and Clinical Advisory Boards [globenewswire.com]
Vascular Graft Market Worth Over USD 3.6 Billion by 2024: Global Market Insights, Inc. [prnewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.